• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    Johnson & Johnson Joins UBS Global Healthcare Conference

    BUSINESSWIRE

    J&J Will Appeal $966M Award By LA Jury In Talcum Powder Lawsuit

    FIERCE PHARMA

    Johnson & Johnson Joins Guggenheim Securities Healthcare Conf

    BUSINESSWIRE

    FDA Approves Tremfya For Pediatric Plaque Psoriasis & Psoriatic

    PR NEWSWIRE

    Icotrokinra Outperforms Deucravacitinib In Head-To-Head Trials

    PHARMAWEB

    Johnson & Johnson Recieves Warning Letter

    FDA

    TREMFYA® Gets US Approval for Subcutaneous Induction in UC Adults

    PR NEWSWIRE

    J&J Gets Positive CHMP Opinion for Nipocalimab in gMG Patients

    GLOBENEWSWIRE

    TECVAYLI & DARZALEX FASPRO Show Promise in New Myeloma Patients

    PR NEWSWIRE

    TREMFYA Gets Positive CHMP Opinion for Ulcerative Colitis Ph 2

    GLOBENEWSWIRE

    J&J`s IL-23 Drug Defeats Sotyktu in Phase 3 Psoriasis Trial

    PR NEWSWIRE

    J&J to Present Neuropsychiatry Innovation at 2025 Psych Congress

    PR NEWSWIRE

    Novartis Falls in Another IRA Price Negotiation Loss for Pharma

    FIERCE PHARMA

    J&J Pursues 1st EMA Approval for Icotrokinra in Plaque Psoriasis

    GLOBENEWSWIRE

    Dr Reddy’s Expands CNS Portfolio With Acquisition of Stugeron

    PRESS RELEASE

    Cullinan, Taiho`s NSCLC Shows `Strong Activity`, Paves Way to FDA

    BIOSPACE

    Ronovo Raises $67M for Surgical Robots with J&J Support

    FIERCE BIOTECH

    US FDA approves J&J`s Bladder Cancer Treatment

    PRESS RELEASE

    Johnson & Johnson Appoints John Morikis to Board of Directors

    BUSINESSWIRE

    Johnson & Johnson to Join Bernstein`s 2nd Annual Healthcare Forum

    BUSINESSWIRE

    AstraZeneca Strengthens Tagrisso`s Position Against J&J Rivalry

    FIERCE PHARMA

    RYBREVANT & LAZCLUZE May Improve Survival in Lung Cancer

    GLOBENEWSWIRE

    Johnson & Johnson to Host Investor Call on Q3 Results

    BUSINESSWIRE

    J&J`s Imaavy Comes up Short in Rheumatoid Arthritis Study

    FIERCE PHARMA

    J&J Drops Development of Arthritis Drug After Trial Setback

    REUTERS

    J&J Boosts US Manufacturing Commitment by $2B Amid Tariff Threats

    BIOSPACE

    AZ, Genentech, Merck top oncology HCP promotions: report

    FIERCE PHARMA

    Johnson & Johnson Joins Morgan Stanley`s 23rd Global Conference

    BUSINESSWIRE

    J&J and Legend Launch First Carvykti TV Ad for Multiple Myeloma

    FIERCE PHARMA

    Boston Jury Awards $42M In Johnson Baby Powder Asbestos Case

    BUSINESSWIRE

    J&J files with U.S. FDA to include new evidence in TREMFYA

    PR NEWSWIRE

    Johnson & Johnson to Participate in 2025 Wells Fargo Health Conf

    BUSINESSWIRE

    EU Okays IMBRUVICA for Untreated Mantle Cell Lymphoma

    GLOBENEWSWIRE

    EU Clears DARZALEX for High-Risk Multiple Myeloma Treatment

    GLOBENEWSWIRE

    EU Approves DARZALEX Faspro® for Multiple Myeloma

    PR NEWSWIRE

    Pacira Bio Expands Zilretta Promotion via Strategic Collaboration

    GLOBENEWSWIRE

    J&J Pursues 1st FDA Approval for Icotrokinra in Plaque Psoriasis

    PR NEWSWIRE

    J&J Gets FDA Priority Review For TAR-200 In High-Risk Cancer

    PR NEWSWIRE

    Johnson & Johnson Raises 2025 Outlook After Q2 Results

    BUSINESSWIRE

    Johnson & Johnson Declares Q3 2025 Quarterly Dividend

    BUSINESSWIRE

    Real Chemistry Appoints Three to Catalyze Change

    FIERCE PHARMA

    J&J Records High Innovative Drug Sales Amid Stelara`s Fall

    FIERCE PHARMA

    J&J Raises Outlook Due to Increased Cardiac Device Sales

    FIERCE BIOTECH

    Caplyta`s Fda Application Shows Schizophrenia Relapse Prevention

    PR NEWSWIRE

    J&J Defeats Generic Drugmakers in Appeal Over Schizophrenia Drug

    REUTERS

    J&J seeks EMA approval to expand Akeega

    GLOBENEWSWIRE

    Janssen’s Biologics Stelara Receives Suppl Approval in US

    FDA

    Nipocalimab better than FcRn blockers for gMG in 24-week study

    GLOBENEWSWIRE

    J&J launches AI surgery funding competition with Nvidia, AWS

    FIERCE BIOTECH

    US Babies Lack Key Gut Bacteria Raising Chronic Disease Risk

    GLOBENEWSWIRE

    Nipocalimab Outperforms FcRn Blockers in gMG ITC Study

    GLOBENEWSWIRE

    Imaavy (nipocalimab-aahu) outperforms FcRn blockers in gMG

    PR NEWSWIRE

    CHMP Backs Darzalex for High-Risk Smouldering Myeloma

    GLOBENEWSWIRE

    IMBRUVICA® (ibrutinib) gets CHMP nod for MCL treatment

    GLOBENEWSWIRE

    Talvey and Tecvayli Combo Effective in Multiple Myeloma Patients

    PR NEWSWIRE

    J&J Lymphoma CAR-T hits 100% ORR in 10 patients

    FIERCE BIOTECH

    Clyra Medical Technologies Names Chris Lyon Chief Revenue Officer

    ACCESSWIRE

    IMBRUVICA Combo Shows Edge Over Acalabrutinib in CLL

    GLOBENEWSWIRE

    Tremfya® Inhibits Joint Damage in Psoriatic Arthritis

    PR NEWSWIRE

    Johnson & Johnson Elects Daniel Pinto to Board

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.